The primary endpoint of endoscopic response at 4-weeks was not reached, but secondary endpoints were nominally significant, favoring antifungal therapy (reduction in Robart’s histological score [74% vs. 33%] and fCal [84% vs. 37%]).
← all excerpts
Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review.
1
—
—